𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic Importance of Tumor Angiogenesis in Breast Carcinoma with Adjuvant Chemotherapy

✍ Scribed by Nazan Gunel; Zafer Akcali; Ugur Coskun; Gülen Akyol; Deniz Yamac; Sibel Yenidünya

Book ID
111731497
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
182 KB
Volume
198
Category
Article
ISSN
0344-0338

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenesis as a prognostic marker in b
Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis
✍ Jacquemier, Jocelyne D.; Penault-Llorca, Frederique M.; Bertucci, Francois; Sun, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

It has now been clearly established that quantitative immunohistochemical methods applied to tumour angiogenesis under suitable quality control conditions are a powerful prognostic tool for use in the initial assessment of breast carcinomas. Appropriate parameters for predicting the aggressiveness o

Tumor angiogenesis is an independent pro
Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
✍ Masakazu Toi; Takeshi Tominaga; Jitsuo Kashitani 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 422 KB

## Jitsuo KASHITANI~ and Takeshi TOMINAGA~ Clinical importance of tumor angiogenesis, especially its significance as a prognostic indicator, was examined in 125 primary breast-cancer patients. The grade of neovascularization was assessed by the vessel density which was obtained by immunocytochemic

The prognostic significance of sialyl-tn
The prognostic significance of sialyl-tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy
✍ Anita Yeomans Kinney; Aysegul Sahin; Sally W. Vernon; Ralph F. Frankowski; John 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 3 views

## Results . Forty-eight (23%) of the 207 specimens demonstrated high STn staining ter, Houston, Texas. (ú25% cells were immunoreactive). During a median follow-up of 5 years, high STn patients had worse disease free survival than low STn patients (55% vs. 74%,